Reason: Registry status: WITHDRAWN
Stage at discontinuation: phase_2
Explore licensed vaccines, adverse event reporting data, and history for this disease.
Multi-Jurisdiction Regulatory Status
Official licensing, rolling submissions, or authorization status tracked across major health authorities.
| Regulatory Authority | Status & Details |
|---|---|
| US FDA | Not Filed / Pre-submission |
| EMA (Europe) | Not Filed / Pre-submission |
| Health Canada | Not Filed / Pre-submission |
| TGA (Australia) | Not Filed / Pre-submission |
Scientific Profile & Documentation
- Platform Architecture
- Inactivated
- Lead Developer
- Novartis
- Next Expected Milestone
- See linked ClinicalTrials.gov records for primary completion dates
- Analyst & Development Notes
- Auto-grouped from 1 ClinicalTrials.gov record(s) sharing intervention/sponsor. Phases and timelines are registry fields and may lag company disclosures.
- Primary Source Documentation
- ClinicalTrials.gov NCT00342940 →
Registered Clinical Trials & Studies
Direct registry links to active, completed, or pivotal registration studies across phases.
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Sub
Milestone Overview
-
Stage VerificationDiscontinued / Inactive confirmed as of 2026-07-10.
-
Target MilestoneSee linked ClinicalTrials.gov records for primary completion dates
Vaccine Data Navigator Candidate Profile Registry:
This candidate profile is indexed across all clinical development levels (Preclinical through Phase 1–3, Regulatory Filing, and Licensure) from primary registry databases (ClinicalTrials.gov, WHO ICTRP, FDA CBER, EMA, Health Canada, TGA Australia). Data are updated continuously to track global biologic and vaccine pipelines.